Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

FDA warns against use of Actra-Rx and Yilishen

The U.S. Food and Drug Administration has warned consumers not to purchase or to consume Actra-Rx or Yilishen, two products promoted and offered for sale on Web sites as "dietary supplements" for treating erectile dysfunction and enhancing sexual performance for men.

4 Nov 2004

Treatment of obesity reduces the onset of lifestyle diseases such as hypertension, high cholesterol levels, diabetes mellitus, and even erectile dysfunction

And according to the University of Adelaide’s Associate Professor Gary Wittert, who is championing The Florey Adelaide Male Ageing Study, there is a compelling argument for an aggressive intervention program given the high prevalence of obesity and the relationship to the aforementioned health problems.

11 Oct 2004

Research shows C. botulinum uses SONO to detect nitric oxide

A deadly bacterium's defense against a mortal molecular enemy illuminates the origins and structure of a vital protein involved in human cell signaling, University of Texas Medical School scientists report in Science Express.

8 Oct 2004

Schering-Plough and Bayer form strategic alliance

Schering-Plough Corporation has announced that it has entered into a strategic agreement with Bayer designed to maximize the companies' pharmaceutical resources while maintaining each company's own strategic interests.

13 Sep 2004

Pfizer files lawsuits against eighteen internet sites for selling illegal copies of LIPITOR

Pfizer has filed lawsuits against a second group of operators of eighteen internet sites for selling unapproved and illegal copies of Pfizer’s leading cholesterol medicine, LIPITOR®, the company said today.

2 Sep 2004

TUNA therapy results in significantly reduced erectile dysfunction

Comparing five-year results of Medtronic TUNA® Therapy (transurethral needle ablation) to surgery for 121 men in their mid-60s with lower urinary tract symptoms caused by an enlarged prostate, a team of urologists found that “for appropriately selected patients with bothersome voiding symptoms, TUNA is an attractive treatment option.”

1 Jul 2004

Exercise helps overweight men with erectile dysfunction

Erectile dysfunction is known to decrease the quality of life in men, and may affect as many as 30 million men in the United States alone, according to the new study. In a previous study, moderate-to-severe erectile dysfunction was reported by 12 percent of men below the age of 59; 22 percent of men aged 60 to 69 years; and 30 percent of 69 years and older.

22 Jun 2004

Erectile dysfunction and type 2 diabetes could mean heart disease

Men who had silent, or symptomless, coronary artery disease (CAD) and type 2 diabetes were nine times as likely to have erectile dysfunction (ED) as were diabetic men who did not have silent heart disease.

22 Jun 2004

Women's health study findings

AllPoints Research today announced the results of a women's health study regarding behavior and perception about sexual and cardiovascular health by women aged 40 and older.

16 Jun 2004

Smoking a lot more harmful than previously thought

The U.S. Surgeon General has released a new comprehensive report on smoking and health, revealing for the first time that smoking causes diseases in nearly every organ of the body. Published 40 years after the surgeon general's first report on smoking -- which concluded that smoking was a definite cause of three serious diseases -- this newest report finds that cigarette smoking is conclusively linked to diseases such as leukemia, cataracts, pneumonia and cancers of the cervix, kidney, pancreas and stomach.

30 May 2004

Smoking causes diseases in nearly every organ of the body

U.S. Surgeon General Richard H. Carmona today released a new comprehensive report on smoking and health, revealing for the first time that smoking causes diseases in nearly every organ of the body.

27 May 2004

Britannia Pharmaceuticals’ partner receives FDA approval for Parkinson’s disease treatment

Britannia Pharmaceuticals Limited announced today that U.S.-based Bertek Pharmaceuticals Inc., the branded subsidiary of Mylan Laboratories Inc has received approval from the Food and Drug Administration for APOKYN (apomorphine hydrochloride injection).

13 May 2004

Leading experts to shed light on controversial testosterone therapy treatment

The use of testosterone therapy will be the topic of a special panel briefing to be held during the 99th Annual Scientific Meeting of the American Urological Association on May 11, 2004 in the Moscone Center in San Francisco.

12 May 2004

20–30 percent of men worldwide are commonly affected by premature ejaculation (PE)

It is one of man's most common, underestimated sexual problems: Ejaculating earlier than desired. More common than erectile dysfunction, this condition can affect men at any point in their lives, and one in four men experience poor control over ejaculation on a frequent basis.

12 May 2004

Botox shows promise as an alternative treatment for benign prostatic hyperplasia

Injections of botulinum toxin A (botox) into the prostate are a promising alternative treatment for the millions of men who have benign prostatic hyperplasia (BPH), a condition commonly referred to as enlarged prostate, according to a study conducted by the University of Pittsburgh School of Medicine and Chang Gung Memorial Hospital in Taiwan.

11 May 2004

Sexual Dysfunction in benign prostatic hyperplasia (BPH) twice as high as physicians estimate

The incidence of sexual dysfunction in patients suffering from Benign Prostatic Hyperplasia (BPH) -- or enlarged prostate -- is nearly twice as high as treating physicians believe shows a new survey from the American Foundation for Urologic Diseases (AFUD) presented today at the American Urological Association annual meeting.

11 May 2004

Men with erectile dysfunction (ED) are 38 percent more likely to have hypertension

This statistical analysis is the largest epidemiological study to confirm this link, and the first to compare men with ED - and those without - for hypertension

10 May 2004

Test results from 1970s linked to rates of erectile problems 25 years later

Age, obesity, high cholesterol, and high triglyceride measurements in midlife predict not only heart disease risks, but also the likelihood of erectile dysfunction decades later, according to a new study in the April 21, 2004 issue of the Journal of the American College of Cardiology.

20 Apr 2004

Oral sildenafil improved exercise tolerance, cardiac output and quality of life in 22 patients with primary pulmonary hypertension

Oral sildenafil (Viagra®) improved exercise tolerance, cardiac output and quality of life in 22 patients with primary pulmonary hypertension, according to the results of the first randomized, placebo-controlled, double-blind, crossover study, reported in the April 7, 2004 issue of the Journal of the American College of Cardiology.

6 Apr 2004

Yohimbe Tree Bark Hold Promise for Revolutionizing Treatment of Anxiety Disorders

New findings at the UCLA Neuropsychiatric Institute demonstrate the potential of a substance found in yohimbe tree bark to accelerate recovery from anxiety disorders suffered by millions of Americans.

4 Apr 2004

Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

FDA warns against use of Actra-Rx and Yilishen

Treatment of obesity reduces the onset of lifestyle diseases such as hypertension, high cholesterol levels, diabetes mellitus, and even erectile dysfunction

Research shows C. botulinum uses SONO to detect nitric oxide

Schering-Plough and Bayer form strategic alliance

Pfizer files lawsuits against eighteen internet sites for selling illegal copies of LIPITOR

TUNA therapy results in significantly reduced erectile dysfunction

Exercise helps overweight men with erectile dysfunction

Erectile dysfunction and type 2 diabetes could mean heart disease

Women's health study findings

Smoking a lot more harmful than previously thought

Smoking causes diseases in nearly every organ of the body

Britannia Pharmaceuticals’ partner receives FDA approval for Parkinson’s disease treatment

Leading experts to shed light on controversial testosterone therapy treatment

20–30 percent of men worldwide are commonly affected by premature ejaculation (PE)

Botox shows promise as an alternative treatment for benign prostatic hyperplasia

Sexual Dysfunction in benign prostatic hyperplasia (BPH) twice as high as physicians estimate

Men with erectile dysfunction (ED) are 38 percent more likely to have hypertension

Test results from 1970s linked to rates of erectile problems 25 years later

Oral sildenafil improved exercise tolerance, cardiac output and quality of life in 22 patients with primary pulmonary hypertension

Yohimbe Tree Bark Hold Promise for Revolutionizing Treatment of Anxiety Disorders

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in